SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $61,222,000 | +320.5% | 384,925 | +153.2% | 0.04% | +258.3% |
Q4 2018 | $14,560,000 | -69.6% | 151,999 | -55.2% | 0.01% | -25.0% |
Q3 2018 | $47,942,000 | +67.3% | 339,410 | +85.4% | 0.02% | -15.8% |
Q2 2018 | $28,658,000 | -22.8% | 183,084 | -20.6% | 0.02% | -24.0% |
Q1 2018 | $37,142,000 | +76.5% | 230,595 | +80.4% | 0.02% | +78.6% |
Q4 2017 | $21,048,000 | +180.3% | 127,790 | +6.0% | 0.01% | +180.0% |
Q3 2017 | $7,508,000 | -23.1% | 120,514 | -1.7% | 0.01% | -28.6% |
Q2 2017 | $9,760,000 | +35.9% | 122,554 | +21.3% | 0.01% | +40.0% |
Q1 2017 | $7,180,000 | +36.7% | 101,027 | -1.8% | 0.01% | +25.0% |
Q4 2016 | $5,252,000 | +11.5% | 102,867 | +0.6% | 0.00% | +33.3% |
Q3 2016 | $4,709,000 | +76.6% | 102,265 | +15.5% | 0.00% | +50.0% |
Q2 2016 | $2,667,000 | +53.3% | 88,521 | +63.1% | 0.00% | +100.0% |
Q1 2016 | $1,740,000 | -41.5% | 54,273 | +6.3% | 0.00% | -50.0% |
Q4 2015 | $2,976,000 | +18.5% | 51,046 | -14.0% | 0.00% | 0.0% |
Q3 2015 | $2,511,000 | -22.8% | 59,328 | +33.2% | 0.00% | 0.0% |
Q2 2015 | $3,252,000 | +298.0% | 44,545 | +173.9% | 0.00% | +100.0% |
Q1 2015 | $817,000 | +55.0% | 16,261 | +13.0% | 0.00% | – |
Q4 2014 | $527,000 | +36.2% | 14,396 | +17.1% | 0.00% | – |
Q3 2014 | $387,000 | – | 12,297 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |